The IV-DLI group showed better engraftment of donor hemopoietic cells than the control group (without DLI) but showed fatal GVHD. such as aplastic anemia, leukemia, and immunodeficiencies [13]. Since then, BMT has been widely used for the treatment of autoimmune diseases, solid malignant tumors, multiple myelomas, myelodysplastic syndrome, and so LCZ696 (Valsartan) on [49]. Allogenic-BMT […]